The impact of race on response to RAAS inhibition.

Current heart failure reports

Volumn 2, Issue 2, 2005, Pages 72-77

  Wallace, Thomas W ^a   Drazner, Mark H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; ISOSORBIDE; OSMOTIC DIURETIC AGENT; VASODILATOR AGENT;

CAUCASIAN; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG COMBINATION; ETHNOLOGY; HEART LEFT VENTRICLE FUNCTION; HUMAN; NEGRO; REVIEW;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLINICAL TRIALS; DIURETICS, OSMOTIC; DRUG THERAPY, COMBINATION; ENALAPRIL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEART FAILURE, CONGESTIVE; HUMANS; HYDRALAZINE; ISOSORBIDE; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 24044498345     PISSN: 15469530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11897-005-0012-4     Document Type: Review

References (23)